Pet Arthritis Market By Product Type (Medications, Assistive Devices, Alternative Therapies, Nutritional Supplements, Others), By Pet Type (Dogs, Cats & Others), By Route of Administration (Oral, Injectable, Topical, Others), By Distribution Channel (Online Pharmacies, Pet Specialty Stores, Veterinary Clinics & Hospitals, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Oct 2024 | Report ID: MI1100 | 215 Pages
Table of Contents
1. Methodology & Report Coverage
1.1. Definition & Objective
1.2. Market Evaluation & forecast parameter
1.3. Research Methodology
1.4. Data Validation Sources
1.4.1. Secondary Research
1.4.2. Primary Research
2. Market Overview
3. Pet Arthritis Market: Market Dynamics
3.1. Executive Summary
3.2. Market Driving Factors
3.2.1. Rising pet ownership boosts demand for arthritis treatments as pets age.
3.2.2. Advances in veterinary medicine are improving and expanding arthritis treatment options for pets.
3.2.3. Rising demand for natural and alternative arthritis treatments is driving market growth.
3.3. Key industry pitfalls & challenges
3.3.1. High costs of arthritis treatments limit accessibility for many pet owners.
3.3.2. Pet owners often hesitate to commit to long-term arthritis treatments due to cost and perceived efficacy.
3.3.3. Concerns over potential side effects from arthritis medications discourage some pet owners from pursuing treatment.
3.4. Market Opportunities
3.4.1. The increasing demand for natural supplements is creating new opportunities in the pet arthritis treatment market.
3.4.2. Innovations in treatment modalities are introducing new, non-invasive options for managing pet arthritis.
3.4.3. Diversifying products for arthritis treatment across various pet species presents new market opportunities.
3.5. Porter’s Five Forces Analysis
3.6. PESTLE Analysis
3.7. Regulatory landscape
3.8. Investment Landscape
3.9. ESG Scenario
3.10. Competitive landscape
3.10.1. Company Market Share
3.10.2. Market Positioning
3.10.3. Strategy framework
3.10.4. Recent Acquisitions & Mergers
4. Pet Arthritis Market, Product Type Segment Analysis
4.1. Overview Dynamics
4.1.1. Market Revenue Share, By Product Type, 2025 & 2035
4.1.2. Key Market Trends, Growth Factors, & Opportunities
4.2. Medications
4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.3. Assistive Devices
4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.4. Alternative Therapies
4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.5. Nutritional Supplements
4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
5. Pet Arthritis Market, Pet Type Segment Analysis
5.1. Overview
5.1.1. Market Revenue Share, By Pet Type, 2025 & 2035
5.1.2. Key Market Trends, Growth Factors, & Opportunities
5.2. Dogs
5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
5.3. Cats
5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
5.4. Others
5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
6. Pet Arthritis Market, Route of Administration Segment Analysis
6.1. Overview
6.1.1. Market Revenue Share, By Route of Administration, 2025 & 2035
6.1.2. Key Market Trends, Growth Factors, & Opportunities
6.2. Oral
6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
6.3. Injectable
6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
6.4. Topical
6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
6.5. Others
6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
7. Pet Arthritis Market, Distribution Channel Segment Analysis
7.1. Overview
7.1.1. Market Revenue Share, By Distribution Channel, 2025 & 2035
7.1.2. Key Market Trends, Growth Factors, & Opportunities
7.2. Online Pharmacies
7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
7.3. Pet Specialty Stores
7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
7.4. Veterinary Clinics & Hospitals
7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
7.5. Others
7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
8. Pet Arthritis Market, Region Segment Analysis
8.1. Overview
8.1.1. Global Market Revenue Share, By Region, 2025 & 2035
8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)
8.2. North America
8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)
8.2.2. North America Market Revenue, By Product Type, 2025-2035
8.2.3. North America Market Revenue, By Pet Type, 2025-2035
8.2.4. North America Market Revenue, ByRoute of Administration, 2025-2035
8.2.5. North America Market Revenue, By Distribution Channel, 2025-2035
8.2.6. The U.S.
8.2.6.1. U.S. Market Revenue, By Product Type, 2025-2035
8.2.6.2. U.S. Market Revenue, By Pet Type, 2025-2035
8.2.6.3. U.S. Market Revenue, ByRoute of Administration, 2025-2035
8.2.6.4. U.S. Market Revenue, By Distribution Channel, 2025-2035
8.2.7. Canada
8.2.7.1. Canada Market Revenue, By Product Type, 2025-2035
8.2.7.2. Canada Market Revenue, By Pet Type, 2025-2035
8.2.7.3. Canada Market Revenue, By Route of Administration, 2025-2035
8.2.7.4. Canada Market Revenue, By Distribution Channel, 2025-2035
8.3. Europe
8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)
8.3.2. Europe Market Revenue, By Product Type, 2025-2035
8.3.3. Europe Market Revenue, By Pet Type, 2025-2035
8.3.4. Europe Market Revenue, By Route of Administration, 2025-2035
8.3.5. Europe Market Revenue, By Distribution Channel, 2025-2035
8.3.6. Germany
8.3.6.1. Germany Market Revenue, By Product Type, 2025-2035
8.3.6.2. Germany Market Revenue, By Pet Type, 2025-2035
8.3.6.3. Germany Market Revenue, By Route of Administration, 2025-2035
8.3.6.4. Germany Market Revenue, By Distribution Channel, 2025-2035
8.3.7. France
8.3.7.1. France Market Revenue, By Product Type, 2025-2035
8.3.7.2. France Market Revenue, By Pet Type, 2025-2035
8.3.7.3. France Market Revenue, By Route of Administration, 2025-2035
8.3.7.4. France Market Revenue, By Distribution Channel, 2025-2035
8.3.8. U.K.
8.3.8.1. U.K. Market Revenue, By Product Type, 2025-2035
8.3.8.2. U.K. Market Revenue, By Pet Type, 2025-2035
8.3.8.3. U.K. Market Revenue, By Route of Administration, 2025-2035
8.3.8.4. U.K. Market Revenue, By Distribution Channel, 2025-2035
8.3.9. Italy
8.3.9.1. Italy Market Revenue, By Product Type, 2025-2035
8.3.9.2. Italy Market Revenue, By Pet Type, 2025-2035
8.3.9.3. Italy Market Revenue, By Route of Administration, 2025-2035
8.3.9.4. Italy Market Revenue, By Distribution Channel, 2025-2035
8.3.10. Spain
8.3.10.1. Spain Market Revenue, By Product Type, 2025-2035
8.3.10.2. Spain Market Revenue, By Pet Type, 2025-2035
8.3.10.3. Spain Market Revenue, By Route of Administration, 2025-2035
8.3.10.4. Spain Market Revenue, By Distribution Channel, 2025-2035
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Market Revenue, By Product Type, 2025-2035
8.3.11.2. Rest of Europe Market Revenue, By Pet Type, 2025-2035
8.3.11.3. Rest of Europe Market Revenue, By Route of Administration, 2025-2035
8.3.11.4. Rest of Europe Market Revenue, By Distribution Channel, 2025-2035
8.4. Asia Pacific
8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)
8.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035
8.4.3. Asia Pacific Market Revenue, By Pet Type, 2025-2035
8.4.4. Asia Pacific Market Revenue, By Route of Administration, 2025-2035
8.4.5. Asia Pacific Market Revenue, By Distribution Channel, 2025-2035
8.4.6. China
8.4.6.1. China Market Revenue, By Product Type, 2025-2035
8.4.6.2. China Market Revenue, By Pet Type, 2025-2035
8.4.6.3. China Market Revenue, By Route of Administration, 2025-2035
8.4.6.4. China Market Revenue, By Distribution Channel, 2025-2035
8.4.7. Japan
8.4.7.1. Japan Market Revenue, By Product Type, 2025-2035
8.4.7.2. Japan Market Revenue, By Pet Type, 2025-2035
8.4.7.3. Japan Market Revenue, By Route of Administration, 2025-2035
8.4.7.4. Japan Market Revenue, By Distribution Channel, 2025-2035
8.4.8. India
8.4.8.1. India Market Revenue, By Product Type, 2025-2035
8.4.8.2. India Market Revenue, By Pet Type, 2025-2035
8.4.8.3. India Market Revenue, By Route of Administration, 2025-2035
8.4.8.4. India Market Revenue, By Distribution Channel, 2025-2035
8.4.9. Australia
8.4.9.1. Australia Market Revenue, By Product Type, 2025-2035
8.4.9.2. Australia Market Revenue, By Pet Type, 2025-2035
8.4.9.3. Australia Market Revenue, By Route of Administration, 2025-2035
8.4.9.4. Australia Market Revenue, By Distribution Channel, 2025-2035
8.4.10. South Korea
8.4.10.1. South Korea Market Revenue, By Product Type, 2025-2035
8.4.10.2. South Korea Market Revenue, By Pet Type, 2025-2035
8.4.10.3. South Korea Market Revenue, By Route of Administration, 2025-2035
8.4.10.4. South Korea Market Revenue, By Distribution Channel, 2025-2035
8.4.11. Singapore
8.4.11.1. Singapore Market Revenue, By Product Type, 2025-2035
8.4.11.2. Singapore Market Revenue, By Pet Type, 2025-2035
8.4.11.3. Singapore Market Revenue, By Route of Administration, 2025-2035
8.4.11.4. Singapore Market Revenue, By Distribution Channel, 2025-2035
8.4.12. Rest of Asia Pacific
8.4.12.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035
8.4.12.2. Rest of Asia Pacific Market Revenue, By Pet Type, 2025-2035
8.4.12.3. Rest of Asia Pacific Market Revenue, By Route of Administration, 2025-2035
8.4.12.4. Rest of Asia Pacific Market Revenue, By Distribution Channel, 2025-2035
8.5. Latin America
8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)
8.5.2. Latin America Market Revenue, By Product Type, 2025-2035
8.5.3. Latin America Market Revenue, By Pet Type, 2025-2035
8.5.4. Latin America Market Revenue, By Route of Administration, 2025-2035
8.5.5. Latin America Market Revenue, By Distribution Channel, 2025-2035
8.5.6. Brazil
8.5.6.1. Brazil Market Revenue, By Product Type, 2025-2035
8.5.6.2. Brazil Market Revenue, By Pet Type, 2025-2035
8.5.6.3. Brazil Market Revenue, By Route of Administration, 2025-2035
8.5.6.4. Brazil Market Revenue, By Distribution Channel, 2025-2035
8.5.7. Argentina
8.5.7.1. Argentina Market Revenue, By Product Type, 2025-2035
8.5.7.2. Argentina Market Revenue, By Pet Type, 2025-2035
8.5.7.3. Argentina Market Revenue, By Route of Administration, 2025-2035
8.5.7.4. Argentina Market Revenue, By Distribution Channel, 2025-2035
8.5.8. Mexico
8.5.8.1. Mexico Market Revenue, By Product Type, 2025-2035
8.5.8.2. Mexico Market Revenue, By Pet Type, 2025-2035
8.5.8.3. Mexico Market Revenue, By Route of Administration, 2025-2035
8.5.8.4. Mexico Market Revenue, By Distribution Channel, 2025-2035
8.5.9. Rest of Latin America
8.5.9.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035
8.5.9.2. Rest of Latin America Market Revenue, By Pet Type, 2025-2035
8.5.9.3. Rest of Latin America Market Revenue, By Route of Administration, 2025-2035
8.5.9.4. Rest of Latin America Market Revenue, By Distribution Channel, 2025-2035
8.6. MEA
8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)
8.6.2. MEA Market Revenue, By Product Type, 2025-2035
8.6.3. MEA Market Revenue, By Pet Type, 2025-2035
8.6.4. MEA Market Revenue, By Route of Administration, 2025-2035
8.6.5. MEA Market Revenue, By Distribution Channel, 2025-2035
8.6.6. GCC Countries
8.6.6.1. GCC Countries Market Revenue, By Product Type, 2025-2035
8.6.6.2. GCC Countries Market Revenue, By Pet Type, 2025-2035
8.6.6.3. GCC Countries Market Revenue, By Route of Administration, 2025-2035
8.6.6.4. GCC Countries Market Revenue, By Distribution Channel, 2025-2035
8.6.7. South Africa
8.6.7.1. South Africa Market Revenue, By Product Type, 2025-2035
8.6.7.2. South Africa Market Revenue, By Pet Type, 2025-2035
8.6.7.3. South Africa Market Revenue, By Route of Administration, 2025-2035
8.6.7.4. South Africa Market Revenue, By Distribution Channel, 2025-2035
8.6.8. Rest of Middle-East & Africa
8.6.8.1. Rest of Middle-East & Africa Market Revenue, By Product Type, 2025-2035
8.6.8.2. Rest of Middle-East & Africa Market Revenue, By Pet Type, 2025-2035
8.6.8.3. Rest of Middle-East & Africa Market Revenue, By Route of Administration, 2025-2035
8.6.8.4. Rest of Middle-East & Africa Market Revenue, By Distribution Channel, 2025-2035
9. Company Profile
9.1. Zoetis Inc.
9.1.1. Business Overview
9.1.2. Financial Performance
9.1.3. Product/Service Offerings
9.1.4. Strategies & recent developments
9.1.5. SWOT Analysis
9.2. Boehringer Ingelheim
9.2.1. Business Overview
9.2.2. Financial Performance
9.2.3. Product/Service Offerings
9.2.4. Strategies & recent developments
9.2.5. SWOT Analysis
9.3. Elanco Animal Health
9.3.1. Business Overview
9.3.2. Financial Performance
9.3.3. Product/Service Offerings
9.3.4. Strategies & recent developments
9.3.5. SWOT Analysis
9.4. Merial (Boehringer Ingelheim)
9.4.1. Business Overview
9.4.2. Financial Performance
9.4.3. Product/Service Offerings
9.4.4. Strategies & recent developments
9.4.5. SWOT Analysis
9.5. PetMed Express, Inc.
9.5.1. Business Overview
9.5.2. Financial Performance
9.5.3. Product/Service Offerings
9.5.4. Strategies & recent developments
9.5.5. SWOT Analysis
9.6. Vetoquinol
9.6.1. Business Overview
9.6.2. Financial Performance
9.6.3. Product/Service Offerings
9.6.4. Strategies & recent developments
9.6.5. SWOT Analysis
9.7. Nutramax Laboratories
9.7.1. Business Overview
9.7.2. Financial Performance
9.7.3. Product/Service Offerings
9.7.4. Strategies & recent developments
9.7.5. SWOT Analysis
9.8. Bayer Animal Health
9.8.1. Business Overview
9.8.2. Financial Performance
9.8.3. Product/Service Offerings
9.8.4. Strategies & recent developments
9.8.5. SWOT Analysis
9.9. MediVet
9.9.1. Business Overview
9.9.2. Financial Performance
9.9.3. Product/Service Offerings
9.9.4. Strategies & recent developments
9.9.5. SWOT Analysis
9.10. PawMed
9.10.1. Business Overview
9.10.2. Financial Performance
9.10.3. Product/Service Offerings
9.10.4. Strategies & recent developments
9.10.5. SWOT Analysis
9.11. Hyalun
9.11.1. Business Overview
9.11.2. Financial Performance
9.11.3. Product/Service Offerings
9.11.4. Strategies & recent developments
9.11.5. SWOT Analysis
9.12. VetriScience Laboratories
9.12.1. Business Overview
9.12.2. Financial Performance
9.12.3. Product/Service Offerings
9.12.4. Strategies & recent developments
9.12.5. SWOT Analysis
9.13. KVP International
9.13.1. Business Overview
9.13.2. Financial Performance
9.13.3. Product/Service Offerings
9.13.4. Strategies & recent developments
9.13.5. SWOT Analysis
9.14. Thorne Research
9.14.1. Business Overview
9.14.2. Financial Performance
9.14.3. Product/Service Offerings
9.14.4. Strategies & recent developments
9.14.5. SWOT Analysis
9.15. Canna-Pet
9.15.1. Business Overview
9.15.2. Financial Performance
9.15.3. Product/Service Offerings
9.15.4. Strategies & recent developments
9.15.5. SWOT Analysis
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.